Receptor Activator of Nuclear Factor (Nf)-kb Ligand Promotes T Helper 17 Cell Differentiation through Fas

References

• Ahern E, Smyth MJ, Dougall WC, Teng MWL. 2018. Roles of the RANKL-RANK axis in antitumour immunity - implications for therapy. Nat Rev Clin Oncol. 15(11):676–93.
   PubMed Web of Science ®Google Scholar
• Anderson DM, Maraskovsky E, Billingsley WL, Dougall WC, Tometsko ME, Roux ER, Teepe MC, DuBose RF, Cosman D, Galibert L. 1997. A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function. Nature. 390(6656):175–79.
   PubMed Web of Science ®Google Scholar
• Bar E, Whitney PG, Moor K, Reis e Sousa C, LeibundGut-Landmann S. 2014. IL-17 regulates systemic fungal immunity by controlling the functional competence of NK cells. Immunity. 40(1):117–27.
   PubMed Web of Science ®Google Scholar
• Bazzazi H, Aghaei M, Memarian A, Asgarian-Omran H, Behnampour N, Yazdani Y. 2018. Th1-Th17 Ratio as a New Insight in Rheumatoid Arthritis Disease. Iran J Allergy Asthma Immunol. 17(1):68–77.
   PubMed Web of Science ®Google Scholar
• Bishop KA, Meyer MB, Pike JW. 2009. A novel distal enhancer mediates cytokine induction of mouse RANKl gene expression. Mol Endocrinol. 23(12):2095–110.
   PubMedGoogle Scholar
• Chen NJ, Huang MW, Hsieh SL. 2001. Enhanced secretion of IFN-gamma by activated Th1 cells occurs via reverse signaling through TNF-related activation-induced cytokine. J Immunol. 166(1):270–76.
   PubMed Web of Science ®Google Scholar
• Du F, Garg AV, Kosar K, Majumder S, Kugler DG, Mir GH, Maggio M, Henkel M, Lacy-Hulbert A, McGeachy MJ. 2016. Inflammatory Th17 cells express integrin alphavbeta3 for pathogenic function. Cell Rep. 16(5):1339–51.
   PubMed Web of Science ®Google Scholar
• Fang S, Zhang S, Huang Y, Wu Y, Lu Y, Zhong S, Liu X, Wang Y, Li Y, Sun J, et al. 2020. Evidence for associations between Th1/Th17 “Hybrid” phenotype and altered lipometabolism in very severe graves orbitopathy. J Clin Endocrinol Metab. 105(6):1851–67.
   Web of Science ®Google Scholar
• Feng R, Morine Y, Ikemoto T, Imura S, Iwahashi S, Saito Y, Shimada M. 2018. Nrf2 activation drive macrophages polarization and cancer cell epithelial-mesenchymal transition during interaction. Cell Commun Signal. 16(1):54.
   PubMedGoogle Scholar
• Izawa T, Ishimaru N, Moriyama K, Kohashi M, Arakaki R, Hayashi Y. 2007. Crosstalk between RANKL and Fas signaling in dendritic cells controls immune tolerance. Blood. 110(1):242–50.
   PubMed Web of Science ®Google Scholar
• Ji JD, Park-Min KH, Shen Z, Fajardo RJ, Goldring SR, McHugh KP, Ivashkiv LB. 2009. Inhibition of RANK expression and osteoclastogenesis by TLRs and IFN-gamma in human osteoclast precursors. J Immunol. 183(11):7223–33.
   PubMed Web of Science ®Google Scholar
• Kamiya S, Okumura M, Chiba Y, Fukawa T, Nakamura C, Nimura N, Mizuguchi J, Wada S, Yoshimoto T. 2011. IL-27 suppresses RANKL expression in CD4+ T cells in part through STAT3. Immunol Lett. 138(1):47–53.
   PubMed Web of Science ®Google Scholar
• Konkel JE, Zhang D, Zanvit P, Chia C, Zangarle-Murray T, Jin W, Wang S, Chen W. 2017. Transforming growth factor-beta signaling in regulatory T cells controls T helper-17 cells and tissue-specific immune responses. Immunity. 46(4):660–74.
   PubMed Web of Science ®Google Scholar
• Korn T, Bettelli E, Oukka M, Kuchroo VK. 2009. IL-17 and Th17 cells. Annu Rev Immunol. 27:485–517.
   PubMed Web of Science ®Google Scholar
• Meyer Zu Horste G, Przybylski D, Schramm MA, Wang C, Schnell A, Lee Y, Sobel R, Regev A, Kuchroo VK. 2018. Fas promotes T helper 17 cell differentiation and inhibits T helper 1 cell development by binding and sequestering transcription factor STAT1. Immunity. 48(3):556–569 e557.
   PubMed Web of Science ®Google Scholar
• Nalbant A, Eskier D. 2016. Genes associated with T helper 17 cell differentiation and function. Front Biosci (Elite Ed). 8:427–35.
   PubMedGoogle Scholar
• Obradovic H, Krstic J, Kukolj T, Trivanovic D, Dordevic IO, Mojsilovic S, Jaukovic A, Jovcic G, Bugarski D, Santibanez JF. 2016. Doxycycline inhibits IL-17-Stimulated MMP-9 expression by downregulating ERK1/2 activation: implications in myogenic differentiation. Mediators Inflamm. 2016:2939658.
   PubMed Web of Science ®Google Scholar
• Okada S, Markle JG, Deenick EK, Mele F, Averbuch D, Lagos M, Alzahrani M, Al-Muhsen S, Halwani R, Ma CS, et al. 2015. IMMUNODEFICIENCIES. Impairment of immunity to Candida and Mycobacterium in humans with bi-allelic RORC mutations. Science. 349(6248):606–13.
   PubMed Web of Science ®Google Scholar
• Perez MM, Martins LMS, Dias MS, Pereira CA, Leite JA, Goncalves ECS, de Almeida PZ, de Freitas EN, Tostes RC, Ramos SG, et al. 2019. Interleukin-17/interleukin-17 receptor axis elicits intestinal neutrophil migration, restrains gut dysbiosis and lipopolysaccharide translocation in high-fat diet-induced metabolic syndrome model. Immunology. 156(4):339–55.
   PubMed Web of Science ®Google Scholar
• Shaw MH, Kamada N, Kim YG, Nunez G. 2012. Microbiota-induced IL-1beta, but not IL-6, is critical for the development of steady-state TH17 cells in the intestine. J Exp Med. 209(2):251–58.
   PubMed Web of Science ®Google Scholar
• Sierra-Filardi E, Nieto C, Dominguez-Soto A, Barroso R, Sanchez-Mateos P, Puig-Kroger A, Lopez-Bravo M, Joven J, Ardavin C, Rodriguez-Fernandez JL, et al. 2014. CCL2 shapes macrophage polarization by GM-CSF and M-CSF: identification of CCL2/CCR2-dependent gene expression profile. J Immunol. 192(8):3858–67.
   PubMed Web of Science ®Google Scholar
• Stockinger B, Omenetti S. 2017. The dichotomous nature of T helper 17 cells. Nat Rev Immunol. 17(9):535–44.
   PubMed Web of Science ®Google Scholar
• Stoppelenburg AJ, De Roock S, Hennus MP, Bont L, Boes M. 2014. Elevated Th17 response in infants undergoing respiratory viral infection. Am J Pathol. 184(5):1274–79.
   PubMed Web of Science ®Google Scholar
• Strengell M, Sareneva T, Foster D, Julkunen I, Matikainen S. 2002. IL-21 up-regulates the expression of genes associated with innate immunity and Th1 response. J Immunol. 169(7):3600–05.
   PubMed Web of Science ®Google Scholar
• Subbarayal B, Chauhan SK, Di Zazzo A, Dana R. 2016. IL-17 augments B cell activation in ocular surface autoimmunity. J Immunol. 197(9):3464–70.
   PubMed Web of Science ®Google Scholar
• Thomson A, Bento DFC, Scurr MJ, Smart K, Somerville MS, Keita AV, Gallimore A, Godkin A. 2021. Prognostic significance of interleukin-17A-producing colorectal tumour antigen-specific T cells. Br J Cancer. 124(9):1552–55.
   PubMedGoogle Scholar
• Tso GH, Law HK, Tu W, Chan GC, Lau YL. 2010. Phagocytosis of apoptotic cells modulates mesenchymal stem cells osteogenic differentiation to enhance IL-17 and RANKL expression on CD4+ T cells. Stem Cells. 28(5):939–54.
   PubMed Web of Science ®Google Scholar
• Wilson NJ, Boniface K, Chan JR, McKenzie BS, Blumenschein WM, Mattson JD, Basham B, Smith K, Chen T, Morel F, et al. 2007. Development, cytokine profile and function of human interleukin 17-producing helper T cells. Nat Immunol. 8(9):950–57.
   PubMed Web of Science ®Google Scholar
• Wong MT, Ong DE, Lim FS, Teng KW, McGovern N, Narayanan S, Ho WQ, Cerny D, Tan HK, Anicete R, et al. 2016. A high-dimensional atlas of human T Cell diversity reveals tissue-specific trafficking and cytokine signatures. Immunity. 45(2):442–56.
   PubMed Web of Science ®Google Scholar
• Wu X, Shou Q, Chen C, Cai H, Zhang J, Tang S, Cai B, Tang D, Cao G. 2017. An herbal formula attenuates collagen-induced arthritis via inhibition of JAK2-STAT3 signaling and regulation of Th17 cells in mice. Oncotarget. 8(27):44242–54.
   PubMedGoogle Scholar
• Xiao S, Yosef N, Yang J, Wang Y, Zhou L, Zhu C, Wu C, Baloglu E, Schmidt D, Ramesh R, et al. 2014. Small-molecule RORgammat antagonists inhibit T helper 17 cell transcriptional network by divergent mechanisms. Immunity. 40(4):477–89.
   PubMed Web of Science ®Google Scholar
• Xu W, Li R, Sun Y. 2019. Increased IFN-gamma-producing Th17/Th1 cells and their association with lung function and current smoking status in patients with chronic obstructive pulmonary disease. BMC Pulm Med. 19(1):137.
   PubMed Web of Science ®Google Scholar
• Yosef N, Shalek AK, Gaublomme JT, Jin H, Lee Y, Awasthi A, Wu C, Karwacz K, Xiao S, Jorgolli M, et al. 2013. Dynamic regulatory network controlling TH17 cell differentiation. Nature. 496(7446):461–68.
   PubMed Web of Science ®Google Scholar
• Zhao M, Tan Y, Peng Q, Huang C, Guo Y, Liang G, Zhu B, Huang Y, Liu A, Wang Z, et al. 2018. IL-6/STAT3 pathway induced deficiency of RFX1 contributes to Th17-dependent autoimmune diseases via epigenetic regulation. Nat Commun. 9(1):583.
   PubMedGoogle Scholar